Fluctuation of lipoprotein metabolism linked with bile acid-activated liver nuclear receptors in Alagille syndrome

Hironori Nagasaka, Takashi Miida, Ken ichi Hirano, Akemi Ota, Kei Murayama, Tohru Yorifuji, Kunihiko Kobayashi, Tomozumi Takatani, Hirokazu Tsukahara, Shu Ping Hui, Masaki Takayanagi, Hitoshi Chiba

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Alagille syndrome (AGS) is a rare hereditary disorder exhibiting fluctuating cholestasis and dyslipidemia. Farnesoid X receptor (FXR) and liver X receptor (LXR) are hepatic nuclear receptors that regulate bile acid and lipoprotein metabolism. To investigate whether cholestasis is related to dyslipidemia and hepatic nuclear receptor expression in AGS patients, we determined the blood levels of total bile acid (TBA) and lipoprotein parameters, and examined hepatic nuclear receptor expression in three AGS children and their three incomplete AGS parents repeatedly over several years. In the AGS children, TBA level showed significant positive correlations with low-density lipoprotein-cholesterol, apolipoprotein E (apoE)-rich high-density lipoprotein-cholesterol (HDL-C), apoA-I, apoE, and cholesteryl ester transfer protein (CETP) concentrations, but negative correlation with apoE-poor HDL-C concentration. Western blot analysis of liver biopsy specimens revealed that FXR and LXR expression increased in parallel with TBA level. CETP- and ATP-binding cassette transporter A1 expression also increased with TBA level, while scavenger receptor class B type-I expression showed the opposite response. However, apoA-I expression was similar to the control level at any TBA level. In the incomplete AGS parents, TBA and lipoprotein parameters showed little fluctuation. In summary, cholestasis is closely related to dyslipidemia and hepatic nuclear receptor expression in AGS patients.

Original languageEnglish
Pages (from-to)434-440
Number of pages7
JournalAtherosclerosis
Volume198
Issue number2
DOIs
Publication statusPublished - Jun 2008
Externally publishedYes

Fingerprint

Alagille Syndrome
Cytoplasmic and Nuclear Receptors
Bile Acids and Salts
Lipoproteins
Liver
Cholestasis
Apolipoproteins E
Dyslipidemias
Cholesterol Ester Transfer Proteins
Apolipoprotein A-I
HDL Cholesterol
Parents
CD36 Antigens
ATP-Binding Cassette Transporters
Protein Binding
LDL Cholesterol
Western Blotting
Biopsy

Keywords

  • Apolipoprotein E
  • CETP
  • Cholestasis
  • FXR
  • HDL
  • LXR
  • SR-BI

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Fluctuation of lipoprotein metabolism linked with bile acid-activated liver nuclear receptors in Alagille syndrome. / Nagasaka, Hironori; Miida, Takashi; Hirano, Ken ichi; Ota, Akemi; Murayama, Kei; Yorifuji, Tohru; Kobayashi, Kunihiko; Takatani, Tomozumi; Tsukahara, Hirokazu; Hui, Shu Ping; Takayanagi, Masaki; Chiba, Hitoshi.

In: Atherosclerosis, Vol. 198, No. 2, 06.2008, p. 434-440.

Research output: Contribution to journalArticle

Nagasaka, H, Miida, T, Hirano, KI, Ota, A, Murayama, K, Yorifuji, T, Kobayashi, K, Takatani, T, Tsukahara, H, Hui, SP, Takayanagi, M & Chiba, H 2008, 'Fluctuation of lipoprotein metabolism linked with bile acid-activated liver nuclear receptors in Alagille syndrome', Atherosclerosis, vol. 198, no. 2, pp. 434-440. https://doi.org/10.1016/j.atherosclerosis.2008.02.020
Nagasaka, Hironori ; Miida, Takashi ; Hirano, Ken ichi ; Ota, Akemi ; Murayama, Kei ; Yorifuji, Tohru ; Kobayashi, Kunihiko ; Takatani, Tomozumi ; Tsukahara, Hirokazu ; Hui, Shu Ping ; Takayanagi, Masaki ; Chiba, Hitoshi. / Fluctuation of lipoprotein metabolism linked with bile acid-activated liver nuclear receptors in Alagille syndrome. In: Atherosclerosis. 2008 ; Vol. 198, No. 2. pp. 434-440.
@article{4b90412b8cf247d18e206be675827ecd,
title = "Fluctuation of lipoprotein metabolism linked with bile acid-activated liver nuclear receptors in Alagille syndrome",
abstract = "Alagille syndrome (AGS) is a rare hereditary disorder exhibiting fluctuating cholestasis and dyslipidemia. Farnesoid X receptor (FXR) and liver X receptor (LXR) are hepatic nuclear receptors that regulate bile acid and lipoprotein metabolism. To investigate whether cholestasis is related to dyslipidemia and hepatic nuclear receptor expression in AGS patients, we determined the blood levels of total bile acid (TBA) and lipoprotein parameters, and examined hepatic nuclear receptor expression in three AGS children and their three incomplete AGS parents repeatedly over several years. In the AGS children, TBA level showed significant positive correlations with low-density lipoprotein-cholesterol, apolipoprotein E (apoE)-rich high-density lipoprotein-cholesterol (HDL-C), apoA-I, apoE, and cholesteryl ester transfer protein (CETP) concentrations, but negative correlation with apoE-poor HDL-C concentration. Western blot analysis of liver biopsy specimens revealed that FXR and LXR expression increased in parallel with TBA level. CETP- and ATP-binding cassette transporter A1 expression also increased with TBA level, while scavenger receptor class B type-I expression showed the opposite response. However, apoA-I expression was similar to the control level at any TBA level. In the incomplete AGS parents, TBA and lipoprotein parameters showed little fluctuation. In summary, cholestasis is closely related to dyslipidemia and hepatic nuclear receptor expression in AGS patients.",
keywords = "Apolipoprotein E, CETP, Cholestasis, FXR, HDL, LXR, SR-BI",
author = "Hironori Nagasaka and Takashi Miida and Hirano, {Ken ichi} and Akemi Ota and Kei Murayama and Tohru Yorifuji and Kunihiko Kobayashi and Tomozumi Takatani and Hirokazu Tsukahara and Hui, {Shu Ping} and Masaki Takayanagi and Hitoshi Chiba",
year = "2008",
month = "6",
doi = "10.1016/j.atherosclerosis.2008.02.020",
language = "English",
volume = "198",
pages = "434--440",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Fluctuation of lipoprotein metabolism linked with bile acid-activated liver nuclear receptors in Alagille syndrome

AU - Nagasaka, Hironori

AU - Miida, Takashi

AU - Hirano, Ken ichi

AU - Ota, Akemi

AU - Murayama, Kei

AU - Yorifuji, Tohru

AU - Kobayashi, Kunihiko

AU - Takatani, Tomozumi

AU - Tsukahara, Hirokazu

AU - Hui, Shu Ping

AU - Takayanagi, Masaki

AU - Chiba, Hitoshi

PY - 2008/6

Y1 - 2008/6

N2 - Alagille syndrome (AGS) is a rare hereditary disorder exhibiting fluctuating cholestasis and dyslipidemia. Farnesoid X receptor (FXR) and liver X receptor (LXR) are hepatic nuclear receptors that regulate bile acid and lipoprotein metabolism. To investigate whether cholestasis is related to dyslipidemia and hepatic nuclear receptor expression in AGS patients, we determined the blood levels of total bile acid (TBA) and lipoprotein parameters, and examined hepatic nuclear receptor expression in three AGS children and their three incomplete AGS parents repeatedly over several years. In the AGS children, TBA level showed significant positive correlations with low-density lipoprotein-cholesterol, apolipoprotein E (apoE)-rich high-density lipoprotein-cholesterol (HDL-C), apoA-I, apoE, and cholesteryl ester transfer protein (CETP) concentrations, but negative correlation with apoE-poor HDL-C concentration. Western blot analysis of liver biopsy specimens revealed that FXR and LXR expression increased in parallel with TBA level. CETP- and ATP-binding cassette transporter A1 expression also increased with TBA level, while scavenger receptor class B type-I expression showed the opposite response. However, apoA-I expression was similar to the control level at any TBA level. In the incomplete AGS parents, TBA and lipoprotein parameters showed little fluctuation. In summary, cholestasis is closely related to dyslipidemia and hepatic nuclear receptor expression in AGS patients.

AB - Alagille syndrome (AGS) is a rare hereditary disorder exhibiting fluctuating cholestasis and dyslipidemia. Farnesoid X receptor (FXR) and liver X receptor (LXR) are hepatic nuclear receptors that regulate bile acid and lipoprotein metabolism. To investigate whether cholestasis is related to dyslipidemia and hepatic nuclear receptor expression in AGS patients, we determined the blood levels of total bile acid (TBA) and lipoprotein parameters, and examined hepatic nuclear receptor expression in three AGS children and their three incomplete AGS parents repeatedly over several years. In the AGS children, TBA level showed significant positive correlations with low-density lipoprotein-cholesterol, apolipoprotein E (apoE)-rich high-density lipoprotein-cholesterol (HDL-C), apoA-I, apoE, and cholesteryl ester transfer protein (CETP) concentrations, but negative correlation with apoE-poor HDL-C concentration. Western blot analysis of liver biopsy specimens revealed that FXR and LXR expression increased in parallel with TBA level. CETP- and ATP-binding cassette transporter A1 expression also increased with TBA level, while scavenger receptor class B type-I expression showed the opposite response. However, apoA-I expression was similar to the control level at any TBA level. In the incomplete AGS parents, TBA and lipoprotein parameters showed little fluctuation. In summary, cholestasis is closely related to dyslipidemia and hepatic nuclear receptor expression in AGS patients.

KW - Apolipoprotein E

KW - CETP

KW - Cholestasis

KW - FXR

KW - HDL

KW - LXR

KW - SR-BI

UR - http://www.scopus.com/inward/record.url?scp=43949138566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43949138566&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2008.02.020

DO - 10.1016/j.atherosclerosis.2008.02.020

M3 - Article

C2 - 18430427

AN - SCOPUS:43949138566

VL - 198

SP - 434

EP - 440

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 2

ER -